Report Categories
View AllRecent Articles
View All
VKTX Viking Therapeutics Inc reports far wider Q4 2025 loss than estimates shares dip 02 percent after earnings
Allogene ALLO Stock Virtual Order Hovering 20260418
VNT Vontier Corporation delivers inline Q4 2025 EPS as shares rise 228 percent on steady investor sentiment
Market Moves Tech lifts Nasdaq as consumer lags and Dow dips
Callaway CALY Competitive Edge Q4 2025 Profit Exceeds Views
Nektar Therapeutics NKTR Top Gainer Nektar Therapeutics beats EPS estimates by 295
MSBI Midland States Bancorp Inc Q4 2025 earnings trail analyst forecasts as shares post mild gains in daily trading
FE FirstEnergy Corp Q4 2025 EPS lands 66 below analyst estimates shares dip 095 today
CADL Candel Therapeutics Inc reports wide Q4 2025 EPS miss while notching slight share gains on stable investor sentiment